Early Experience of High-dose Intravenous <i>Mycobacterium w</i> in Critically Ill Patients of COVID-19.

Patel, Parth Sudhendu; Patel, Sudhendu; Shah, Vidhi; Aswani, Varsha; Narwaria, Mahendra

Early Experience of High-dose Intravenous Mycobacterium w in Critically Ill Patients of COVID-19.

Patel, Parth Sudhendu; Patel, Sudhendu; Shah, Vidhi; Aswani, Varsha; Narwaria, Mahendra.

Afiliação

Patel PS; Department of Critical Care, Bombay Hospital, Institute of Medical Sciences, Ahmedabad, Gujarat, India.
Patel S; Department of Medicine, Sterling Hospital, Ahmedabad, Gujarat, India.
Shah V; Department of Medicine, Sterling Hospital, Ahmedabad, Gujarat, India.
Aswani V; Department of Surgery, VS Hospital, Ahmedabad, Gujarat, India.
Narwaria M; Department of Surgery, Asian Bariatrics Hospital, Ahmedabad, Gujarat, India.

Indian J Crit Care Med ; 25(9): 1066-1068, 2021 Sep.

Article em En | MEDLINE | ID: mdl-34963729

Palavras-chave

COVID-19; Immune dysregulation; Immunomodulator; Mycobacterium w

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Ano de publicação: 2021 Tipo de documento: Article